Elevated fetal hemoglobin (HbF) in adults, though well-documented, remains a point of interest in clinical diagnostics, particularly in HbA1c testing. HbF is a type of hemoglobin...
This type of blood test still needs to be studied in clinical trials before being considered for approval by the Food and Drug Administration as a screening tool to help predict...
Now more than ever, laboratories are tasked with the combined aim of maximizing test volume and reliability, while minimizing turnaround time (TAT) and cost. Automation is an ...
Phlebotomy — collecting a blood specimen directly from the circulatory system via puncture for analysis and diagnosis — is one of the most common invasive procedures...
Laboratory errors can lead to errors in diagnosis and may cause increased costs, unnecessary testing and/or treatment, and adverse patient outcomes. Approximately 60–70%...
Circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) can reduce costs by up to 21% across health plan populations when half of eligible patients with stage...
All performance and safety endpoints were met in A.D.O.P.T. Pivotal Trial Study Phase; other key findings include 95% first-stick success and 98% patient acceptance.